These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 9272295

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 3. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J, Cabral AR, Alarcón-Segovia D.
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [Abstract] [Full Text] [Related]

  • 4. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

  • 9. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, Moutsopoulos HM.
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [Abstract] [Full Text] [Related]

  • 10. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U, Yayla ME, Ateş A, Okatan İE, Yurteri EU, Torgutalp M, Keleşoğlu ABD, Turgay TM, Kınıklı G.
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [Abstract] [Full Text] [Related]

  • 11. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
    Idborg H, Zandian A, Sandberg AS, Nilsson B, Elvin K, Truedsson L, Sohrabian A, Rönnelid J, Mo J, Grosso G, Kvarnström M, Gunnarsson I, Lehtiö J, Nilsson P, Svenungsson E, Jakobsson PJ.
    Arthritis Res Ther; 2019 Feb 18; 21(1):62. PubMed ID: 30777133
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Antiphospholipid syndrome and stroke].
    Kitagawa Y.
    Rinsho Shinkeigaku; 2005 Nov 18; 45(11):852-5. PubMed ID: 16447744
    [Abstract] [Full Text] [Related]

  • 14. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E, Glidden DV, Elder ME.
    Arthritis Rheum; 2002 Aug 18; 47(4):414-20. PubMed ID: 12209489
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA.
    J Rheumatol; 2000 Dec 18; 27(12):2833-7. PubMed ID: 11128672
    [Abstract] [Full Text] [Related]

  • 16. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.
    Ann Rheum Dis; 2008 Mar 18; 67(3):395-401. PubMed ID: 17644539
    [Abstract] [Full Text] [Related]

  • 17. Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren's syndrome.
    Pasoto SG, Chakkour HP, Natalino RR, Viana VS, Bueno C, Lianza AC, de Andrade JL, Neto ML, Fuller R, Bonfa E.
    Clin Rheumatol; 2012 Sep 18; 31(9):1331-8. PubMed ID: 22692396
    [Abstract] [Full Text] [Related]

  • 18. The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses.
    Radway-Bright EL, Ravirajan CT, Isenberg DA.
    Rheumatology (Oxford); 2000 Apr 18; 39(4):427-31. PubMed ID: 10817777
    [Abstract] [Full Text] [Related]

  • 19. Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
    Teixidó M, Font J, Reverter JC, Cervera R, Tàssies D, Ingelmo M, Escolar G, Ordinas A.
    Br J Rheumatol; 1997 Jan 18; 36(1):113-6. PubMed ID: 9117149
    [Abstract] [Full Text] [Related]

  • 20. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A, Szodoray P, Kiss E, Kapitany A, Szegedi G, Zeher M.
    Hum Immunol; 2006 Nov 18; 67(11):924-30. PubMed ID: 17145372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.